| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $394K | -10.1% |
| Cost of Revenue | $158K | +16.5% |
| Gross Profit | $236K | -22.0% |
| R&D Expense | $771K | +43.1% |
| SG&A Expense | $4.7M | +10.5% |
| Operating Income | -$5.8M | -23.7% |
| Net Income | -$5.7M | -19.1% |
| EPS (Basic) | -$1.64 | +20.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | -15.6% |
| Accounts Receivable | $193K | +11.6% |
| Inventory | $82K | +261.5% |
| Current Assets | $6.3M | -13.2% |
| Total Assets | $6.5M | -14.5% |
| Current Liabilities | $715K | -23.2% |
| Total Liabilities | $755K | -36.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -24.4% |
| Capital Expenditures | $52K | -23.7% |
| Investing Cash Flow | -$52K | +37.6% |
| Financing Cash Flow | $4.1M | -61.8% |
| Free Cash Flow | -$5.1M | -23.6% |
| Stockholders' Equity |
| $5.8M |
| -9.8% |